Our expertise
Lockwood leverages decades of experience in the rare disease space, partnering with Commercial, Medical, Publications, Market Access, and Digital teams for both US and Global initiatives.
Raising Awareness
- Prioritize disease education
- Help HCPs find patients
- Create urgency to treat
- Equip clinicians and patients
Building Advocates
- Identify the right HCPs
- Engage to build trust
- Gather insights
- Cultivate brand advocates
Connecting Patients
- Understand the complicated rare disease journey
- Link patients to providers
- Navigate the treatment journey
- Provide ongoing support
Showing Commitment
- Address multi-faceted needs of patients, caregivers,
and HCPs - Partner with advocacy groups
- Provide resources where needed
- Support scientific advancement
How lockwood approaches rare disease
We understand the importance of the right strategy at the right time. Our approach is tailored to each stage of a product’s lifecycle.
Prelaunch
Preparing the market by communicating unmet needs.
- KOL development
- Understanding the patient journey
- Defining disease recognition
- Educating multidisciplinary teams
Launch
Moving from unbranded to branded.
- Engaging with KOLs and advocacy groups
- Expanding relationships with brand advocates
- Establishing a care pathway
- Developing optimal outcomes
Postlaunch
Continuous succeeds monitoring and adjustments.
- Changes in treatment patterns
- Addressing data gaps with real-world evidence
- Ongoing community commitment
- Mitigating barriers to HCP and patient access
Our Capabilities
Let’s Work Together
Looking for a trusted partner to elevate your scientific communications?


